Rockville, MD – The Association of Cancer Care Centers (ACCC) has just released a model framework for cancer care providers to use in improving care coordination for lung cancer patients covered by Medicaid. “Improving Care Coordination: A Model for Lung Cancer” is a first-of-its-kind quality improvement tool, now available to cancer programs and practices nationwide.
The Model is based upon an extensive research process and addresses lung cancer care for the patient populations enrolled in Medicaid, as these patients experience more negative lung cancer outcomes.
Led by co-principal investigators Christopher Lathan, MD, MS, MPH, Medical Director, Dana-Farber at St. Elizabeth’s Medical Center and Randall Oyer, MD, Medical Director, Ann B. Barshinger Cancer institute, Penn Medicine Lancaster General Health, the model was developed through peer-to-peer collaboration between industry researchers, lung cancer experts, oncology providers, administrators, epidemiologists, and patient advocates among the project’s Advisory Committee and Technical Expert Panel.
“The number-one deadliest cancer hits this patient population particularly hard for a number of reasons. We were looking to create a central hub where cancer centers could assess their care in specific areas and then access resources to improve those areas of their program,” said Dr. Lathan.
Oncology programs of all sizes can utilize the twelve assessment areas within the Model to analyze strengths and weaknesses, pinpoint barriers to coordinated care, and bolster the quality of the patient journey from diagnosis to survivorship care. Each assessment area is linked to more than 100 quality measures aligned with CMS MIPS, ASCO QOPI, NCQA PCSP, AHRQ CAHPS, and CoC 2020 Cancer Program Standards. The model was designed so any member of a multidisciplinary team can lead the QI effort.
“This is a unique QI model that will help programs regardless of prior experience with self-assessment and self-directed improvement,” said Randall Oyer. “It’s not one size fits all. Regardless of resources, cancer programs of any size can identify areas of interest for improvement that they can address, making the model scalable and effective for quality improvement.”
Participation from lung cancer experts and the cancer community was critical and an important component of the entire model development process. ACCC Cancer Program Members were invited to apply to serve as Testing Sites for the Model, and seven testing sites undertook unique quality improvement projects for a twelve-month period from October 2017 to September 2018. Those centers included the Advocate Lutheran General Hospital Cancer Care Program; Ascension Wheaton Memorial Medical Center; Cowell Family Cancer Center, Munson Healthcare; Florida Hospital Memorial Medical Center; Genesis HealthCare System, Genesis Cancer Care Center; Northwest Medical Specialties, PLLC; and Southern Ohio Medical Center, Southern Ohio Medical Center Cancer Care.
The model is the result of a comprehensive project ACCC launched in 2016 upon receipt of a grant from the Bristol-Myers Squibb Foundation. Cancer programs can access the model on ACCC’s website.
December 21, 2021
December 21, 2021
At the 2026 ASCO Annual Meeting, the Louisiana Oncology Society received the ASCO Jeffrey C Ward Affiliate Advocacy Award for advancing critical advocacy priorities that have translated into meaningful legislative victories. The Iowa Oncology Society and Washington State Medical Oncology Society were also recognized for their advocacy efforts in 2025 at the meeting, receiving second place awards.
